Create a half hour presentation on Romosozumab - the major randomized clinical studies, the major cardiovascular outcome studies with Romosozumab including real world studies
Create a half hour presentation on Romosozumab - the major randomized clinical studies, the major cardiovascular outcome studies with Romosozumab including real world studies
Created using ChatSlide
This lecture reviews romosozumab for patients at very high fracture risk, covering its anabolic mechanism, 12-month treatment sequence, and evidence from FRAME, ARCH, and STRUCTURE. It interprets fracture and BMD outcomes alongside trial design and follow-up, examines the cardiovascular safety signal, and integrates randomized and real-world evidence. A practical decision framework emphasizes assessment of myocardial infarction, stroke, comorbidities, chronic kidney disease, and subsequent...